Recall of Dodextro pain reliever and fever reducer capsules.
Dodextro capsules, used for pain relief, fever reduction, and anti-inflammatory purposes, have been suspended from circulation and recalled nationwide due to failing quality control tests.
 |
The Drug Administration Department (Ministry of Health) stated that the Dodextro capsules whose circulation has been suspended have production batch number: 213904, expiration date: 07/2/2015, registration number: VD-3004-07, manufactured by Dong Nam Pharmaceutical Production and Trading Joint Stock Company.
Previously, the Ho Chi Minh City Institute of Drug Testing took samples of the drug from booth number 4, Codupha Pharmaceutical Center, 334 To Hien Thanh Street, Ward 14, District 10, Ho Chi Minh City for testing. The results showed that the drug did not meet quality standards for the qualitative test of Dextropropoxyphen. Therefore, the entire batch of the drug had to be suspended from circulation and recalled nationwide.
The Drug Administration Department requires the manufacturing company to promptly send recall notices to all distributors and users of Dodextro capsules produced by the company and to recall all batches of the aforementioned substandard drugs.
Provincial and city health departments, and health departments of various sectors, are requested to notify businesses and users of the recalled batch of substandard drugs mentioned above, inspect and supervise the units carrying out the recall, and handle any units that violate regulations according to current laws.
According to HNMO - TH